• Loading stock data…

Volatility Watch

Sangamo Therapeutics Inc.(Nasdaq: SGMO) – Doom Or Gloom Scenario

Recent data release may have changed SGMO's future outlook. Sangamo's long-term chart suggests a potential pullback to $4 is a possibility, but that was before a recent data release by the company … [Read more...] about Sangamo Therapeutics Inc.(Nasdaq: SGMO) – Doom Or Gloom Scenario

Gene therapy treatment for SMA approved! (Full TA)

Gene Therapy for SMA-- Full technical analysis #VolatilityWatch by follow_the_money on TradingView.com RegenexBio (RGNX) and Novartis (NVS) just received FDA approval of Gene Therapy treatment for … [Read more...] about Gene therapy treatment for SMA approved! (Full TA)